Chairman of the Board of Veracyte, Bonnie Anderson, was presented with Wallace H. Coulter Award for Healthcare Innovation Friday at the 2017 BMES Annual Meeting.
Veracyte is a genomic diagnostics company that aims to improve patient care by reducing diagnostic uncertainty - without the need for often-unnecessary surgery. Her career spans over 30 years in regulated diagnostics and life science markets.
Anderson cofounded Veracyte in 2008
During her talk, Anderson said when Veracyte develops technology, the baseline question is always "How does it improve patient care?"
She described how she started Veracyte with just an idea and a business plan - rather than with a technology, which is how most diagnostics companies begin. She focused on identifying specific clinical questions that could be answered with a genomic test and that, when answered, would change what happened next for the patient.
More than 400 people gathered for the annual Women in BME Luncheon help Friday afternoon.
Christopher J. Loving addressed the group; exploring concepts aimed to enhance people's ability to live the lives they envision for themselves.
BMES 2017 attendees celebrated the final full-day of the meeting at the Arizona Science Center.
